Lv0
0 积分 2024-05-29 加入
Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial
3小时前
待确认
Major Comorbidities of Atopic Dermatitis: Beyond Allergic Disorders
20天前
已完结
Current Status of Weekly Insulin Analogs and Their Pharmacokinetic/Pharmacodynamic Evaluation by the Euglycemic Clamp Technique
28天前
已完结
Safety, tolerability, pharmacokinetics and pharmacodynamics of GZR4, a novel once‐weekly basal insulin, in healthy participants: A randomized trial
28天前
已完结
Tacrolimus clinical studies for atopic dermatitis and other conditions
3个月前
已关闭
他克莫司软膏治疗成人特应性皮炎的临床试验
3个月前
已完结
Aerosolized GLP-1 for Treatment of Diabetes Mellitus and Irritable Bowel Syndrome
10个月前
已完结
LY3437943, a novel triple GIP, GLP-1, and glucagon receptor agonist in people with type 2 diabetes: a phase 1b, multicentre, double-blind, placebo-controlled, randomised, multiple-ascending dose trial
1年前
已完结
皖公网安备34019202002308
